Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ACLY | P53396 | 3/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290502 | 1.00 | ALDH1A1 (0.70) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL23607610 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL31078055 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL31272367 | 0.86 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL437150 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL31223219 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL31223216 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL6429247 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL226489 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28846450 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595494-B2 | Biological production of multi-carbon compounds from methane | BIOVERDE TECH LLC (US) | 2026-04-07 | — | — | US | disclosed |
| US-20240368638-A1 | Biological Production of Multi-Carbon Compounds from Methane | INTREXON CORPORATION | 2024-11-07 | — | — | US | disclosed |
| US-11821019-B2 | Biological production of multi-carbon compounds from methane | PRECIGEN, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20210171988-A1 | Biological Production of Multi-Carbon Compounds from Methane | BIOVERDE TECH LLC | 2021-06-10 | — | — | US | disclosed |
| US-10876137-B2 | Biological production of multi-carbon compounds from methane | PRECIGEN, INC. (US) | 2020-12-29 | — | — | US | disclosed |
| US-20170335351-A1 | BIOLOGICAL PRODUCTION OF MULTI-CARBON COMPOUNDS FROM METHANE | INTREXON CORPORATION (US) | 2017-11-23 | — | — | US | disclosed |
| WO-2017194696-A1 | BACTERIAL CELLS WITH IMPROVED TOLERANCE TO ISOBUTYRIC ACID | DANMARKS TEKNISKE UNIVERSITET (DK) | 2017-11-16 | — | — | WO | disclosed |
| US-9745603-B2 | Biological production of multi-carbon compounds from methane | INTREXON CORPORATION (US) | 2017-08-29 | — | — | US | disclosed |
| US-20170152529-A1 | Biological Production of Multi-Carbon Compounds from Methane | INTREXON CORPORATION (US) | 2017-06-01 | — | — | US | disclosed |
| US-9399783-B2 | Biological production of multi-carbon compounds from methane | INTREXON CORPORATION (US) | 2016-07-26 | — | — | US | disclosed |
| US-8048666-B1 | Ethanol production in microorganisms | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-20110262975-A1 | ENGINEERED CO2 FIXING MICROORGANISMS PRODUCING CARBON-BASED PRODUCTS OF INTEREST | c/o JOULE UNLIMITED, INC. (US) | 2011-10-27 | — | — | US | disclosed |
| EP-2344652-A1 | ETHANOL PRODUCTION BY MICROORGANISMS | Joule Unlimited, Inc. (US) | 2011-07-20 | — | — | EP | disclosed |
| US-7981647-B2 | Engineered CO2 fixing microorganisms producing carbon-based products of interest | JOULE UNLIMITED, INC. (US) | 2011-07-19 | — | — | US | disclosed |
| US-7968321-B1 | Ethanol production by microorganisms | JOULE UNLIMITED, INC. (US) | 2011-06-28 | — | — | US | disclosed |
| US-20110151531-A1 | ETHANOL PRODUCTION BY MICROORGANISMS | JOULE UNLIMITED, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| EP-2285948-A1 | ENGINEERED CO2 FIXING MICROORGANISMS PRODUCING CARBON-BASED PRODUCTS OF INTEREST | Joule Unlimited, Inc. (US) | 2011-02-23 | — | — | EP | disclosed |
| US-20110008861-A1 | Engineered CO2 Fixing Microorganisms Producing Carbon-Based Products of Interest | JOULE UNLIMITED, INC. (US) | 2011-01-13 | — | — | US | disclosed |
| WO-2010044960-A1 | ETHANOL PRODUCTION BY MICROORGANISMS | JOULE BIOTECHNOLOGIES, INC. (US) | 2010-04-22 | — | — | WO | disclosed |
| WO-2009111513-A1 | ENGINEERED CO2 FIXING MICROORGANISMS PRODUCING CARBON-BASED PRODUCTS OF INTEREST | JOULE BIOTECHNOLOGIES, INC. (US) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595494-B2 | Biological production of multi-carbon compounds from methane | MLYCD, ADH1C, DERA | ALDH1A1 257/4885HMGCR 526/4885CHRM1 3123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.